The Boeing Company
NYSE: BA • $209.89 • March 15, 2026
12-Month Price Target$285
+35.8% Implied Upside
Basis Report Research | Institutional Equity Research
Executive At-a-Glance
Deterministic snapshot from locked fundamentals. Full evidence registry appears in the Sources section.
Data As OfMar 13, 2026, 8:00 PM
Current Price$209.89
Consensus Upside+29.4%
Next EarningsApr 2026
02 Executive Summary
Boeing has emerged from its darkest operational period with returning profitability and accelerating aircraft deliveries, though execution risks persist across commercial and defense programs. The aerospace giant delivered $89.5B in revenue for FY2025, up 34.5% YoY, while achieving positive net income of $2.2B after three years of losses. Top Catalysts:- 737 MAX production ramp to 38 aircraft/month by mid-2026, driving $12B+ incremental revenue
- Defense segment margin expansion from recent $2.5B contract awards and C-17 program extensions [S10]
- Free cash flow inflection expected in H2 2026 as working capital normalizes and deliveries accelerate
- Regulatory scrutiny remains elevated following Starliner program criticism despite NASA's continued support [S8]
- Supply chain constraints limiting 737 MAX production below target rates through 2026
- Elevated debt burden of $54.4B requires consistent FCF generation to restore investment grade rating
Market Cap$164.9B
Enterprise Value$192.6B
Revenue (TTM)$89.5B
Net Income (TTM)$2.2B
FCF (TTM)$1.8B
P/E84.6x
EV/EBITDA-59.5x
Revenue Growth YoY+57.1%
Net Margin2.5%
ROIC4.1%
Investment Thesis: Boeing's operational recovery is accelerating with 737 MAX deliveries ramping and defense margins expanding, positioning the company for sustained FCF generation and debt reduction over the next 24 months.
03 Financial Performance & Health
3a. Income Statement Analysis
Boeing's financial recovery gained momentum in 2025 with revenue growth of 34.5% to $89.5B, driven primarily by increased 737 MAX deliveries and defense contract execution. The company achieved its first profitable year since 2018, generating $2.2B in net income compared to losses totaling $24.8B over the previous three years. Key performance drivers include:- Commercial airplane segment revenue increased 45% YoY on 51 February deliveries [S11]
- Defense, Space & Security maintained stable margins despite program mix shifts
- Global Services segment contributed steady cash generation with 12% operating margins
- One-time charges declined significantly from peak crisis levels in 2020-2022
| ($B) | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 66.6 | 77.8 | 66.5 | 89.5 | 89.5 |
| Gross Profit | 3.5 | 7.7 | -2.0 | 4.3 | 4.3 |
| Operating Income | -3.5 | -0.8 | -10.8 | -5.4 | -5.4 |
| Net Income | -4.9 | -2.2 | -11.8 | 2.2 | 2.2 |
| Margin Analysis | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|
| Gross Margin % | 5.3% | 9.9% | -3.0% | 4.8% | 4.8% |
| Operating Margin % | -5.3% | -1.1% | -16.3% | -6.1% | -3.2% |
| Net Margin % | -7.4% | -2.9% | -17.8% | 2.5% | 2.5% |
| Revenue Growth YoY | -1.8% | 16.8% | -14.5% | 34.5% | 57.1% |
Margin Recovery Trajectory: Boeing's return to positive net margins reflects operational improvements, though normalized profitability requires 737 MAX production scaling to pre-crisis levels.
3b. Balance Sheet Analysis
Boeing's balance sheet showed meaningful improvement in 2025, with total equity turning positive at $5.5B after four years of negative shareholder equity. The company maintained liquidity of $10.9B in cash while total debt remained elevated at $54.4B, representing a modest increase from prior year levels. Balance sheet strength indicators:- Debt-to-equity ratio improved to 9.9x from negative territory in prior years
- Current ratio maintained above 1.2x supporting near-term liquidity needs
- Net debt of $43.5B requires disciplined FCF generation for credit profile restoration
- Total assets increased 7.6% to $168.2B reflecting business recovery and inventory builds
| ($B) | FY2023 | FY2024 | FY2025 | Latest |
|---|---|---|---|---|
| Total Assets | 137.0 | 156.4 | 168.2 | 168.2 |
| Total Liabilities | 154.2 | 160.3 | 162.8 | 162.8 |
| Total Equity | -17.2 | -3.9 | 5.5 | 5.5 |
| Total Debt | 52.6 | 54.2 | 54.4 | 54.4 |
| Cash & Equivalents | 12.7 | 13.8 | 10.9 | 10.9 |
| Net Debt | 39.9 | 40.4 | 43.5 | 43.5 |
3c. Cash Flow Analysis
Boeing's cash flow profile improved dramatically in 2025 with operating cash flow turning positive at $1.1B, though free cash flow remained negative at -$1.9B due to elevated capital expenditures. The company's FCF performance reflects the typical aerospace cycle where cash generation lags earnings recovery by 12-18 months. Cash generation dynamics:- Operating cash flow improvement of $13.1B YoY driven by working capital optimization
- Capital expenditures increased to $3.0B supporting 737 MAX production expansion
- Free cash flow expected to inflect positive in H2 2026 as deliveries accelerate
- Historical FCF volatility reflects program timing and regulatory impacts
| ($B) | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|
| Operating Cash Flow | 3.5 | 6.0 | -12.1 | 1.1 | 1.1 |
| Capital Expenditures | -1.2 | -1.5 | -2.3 | -3.0 | -3.0 |
| Free Cash Flow | 2.3 | 4.4 | -14.4 | -1.9 | 1.8 |
| FCF Margin % | 3.5% | 5.7% | -21.6% | -2.1% | 2.0% |
3d. Return on Capital
Boeing's capital efficiency metrics remain below target levels but show improvement trajectory. ROE of 40.3% in 2025 reflects low equity base rather than exceptional profitability, while ROIC of 4.1% approaches the company's estimated cost of capital near 8%.Capital Efficiency Recovery: Boeing's ROIC improvement to 4.1% signals operational progress, though reaching double-digit returns requires sustained margin expansion and efficient capital deployment.
04 Valuation
4a. Multiples Analysis
Boeing trades at significant premiums to aerospace peers on traditional metrics, reflecting both recovery expectations and elevated denominator effects from recent losses. The company's forward P/E of 44.6x compares unfavorably to defense contractors but aligns with commercial aerospace recovery precedents. Current valuation positioning:- Forward P/E of 44.6x reflects analyst optimism on 2026 earnings normalization
- EV/Revenue multiple of 2.2x sits below historical aerospace cycle peaks
- Price-to-book of 30.2x distorted by recent equity base rebuilding
- Enterprise value of $192.6B implies substantial execution risk embedded in current price
| Metric | BA (Current) | BA (5-Yr Avg) | Industry Avg | Lockheed Martin | Raytheon | Airbus |
|---|---|---|---|---|---|---|
| P/E | 84.6x | NM | 24.5x | 19.2x | 28.4x | 32.1x |
| Forward P/E | 44.6x | NM | 18.3x | 16.8x | 22.1x | 26.3x |
| EV/Revenue | 2.2x | 1.8x | 1.9x | 2.4x | 2.1x | 1.7x |
| P/B | 30.2x | NM | 3.2x | 4.1x | 2.8x | 2.9x |
| EV/EBITDA | -59.5x | NM | 12.4x | 11.2x | 14.6x | 9.8x |
4b. Discounted Cash Flow (DCF) Analysis
Our DCF model assumes Boeing achieves normalized operating performance by 2028 with 8% revenue CAGR through 2030. We apply a 10.2% WACC reflecting current credit profile and aerospace industry risks, with 2.5% terminal growth rate consistent with long-term GDP expectations. Base case assumptions include:- 737 MAX production reaching 42 aircraft/month by end-2027
- Defense margins expanding to 12% from current 8% levels
- Working capital normalization driving FCF conversion improvement
- Capital expenditures stabilizing at 2.5% of revenue by 2028
| ($B) | 2026E | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|
| Revenue | 95.2 | 102.8 | 110.1 | 117.8 | 125.2 |
| EBITDA | 8.1 | 11.4 | 14.2 | 16.8 | 19.1 |
| Free Cash Flow | 2.8 | 6.2 | 9.4 | 12.1 | 14.3 |
| Scenario | Revenue CAGR | Terminal Growth | WACC | Implied Price | Upside/Downside |
|---|---|---|---|---|---|
| Bull | 10% | 3.0% | 9.5% | $325 | +54.8% |
| Base | 8% | 2.5% | 10.2% | $285 | +35.8% |
| Bear | 6% | 2.0% | 11.0% | $235 | +12.0% |
4c. Valuation Conclusion
Boeing appears undervalued at current levels based on both DCF analysis and peer comparisons, assuming successful execution of production ramp and margin recovery. The stock trades at a 15% discount to our base case DCF value of $285, providing adequate margin of safety given execution risks.Valuation Asymmetry: Boeing's current valuation embeds significant pessimism, with even modest operational improvements supporting 25-35% upside over 12 months.
05 Business Model & Competitive Moat
5a. Business Segments
Boeing operates through three primary segments with Commercial Airplanes representing the largest revenue contributor at approximately 60% of total sales. The Defense, Space & Security segment provides stable government-backed revenues, while Global Services delivers high-margin aftermarket support. Segment performance drivers:- Commercial Airplanes: 737 MAX family dominates narrow-body market with 4,500+ backlog
- Defense segment: F/A-18 Super Hornet and KC-46 tanker programs provide steady cash flow
- Global Services: Parts, modifications, and training generate 15%+ operating margins
- Space programs: Starliner and SLS provide optionality despite recent challenges [S7]
| Segment | Revenue ($B) | % of Total | Growth Rate | Operating Margin |
|---|---|---|---|---|
| Commercial Airplanes | 53.7 | 60% | +42% | 2.1% |
| Defense, Space & Security | 24.3 | 27% | +8% | 8.4% |
| Global Services | 11.5 | 13% | +15% | 14.2% |
5b. Economic Moat Assessment
Boeing maintains a narrow economic moat primarily through scale advantages and switching costs in commercial aviation. The company's competitive position faces pressure from Airbus competition and emerging players in defense markets.| Moat Source | Strength | Explanation |
|---|---|---|
| Brand & Reputation | Moderate | 737 MAX crisis damaged brand but recovery underway |
| Network Effects | Weak | Limited network benefits beyond pilot training |
| Switching Costs | Strong | High airline training and maintenance switching costs |
| Scale Advantages | Strong | Manufacturing scale and R&D spreading enable cost leadership |
| Intellectual Property | Moderate | Substantial patent portfolio but rapid technology evolution |
| Regulatory Barriers | Strong | Certification requirements create significant entry barriers |
Moat Durability: Boeing's narrow moat depends on execution excellence and regulatory confidence restoration, with switching costs and scale providing the most sustainable advantages.
06 Growth Strategy & Future Outlook
6a. Growth Drivers
Boeing's growth strategy centers on 737 MAX production normalization and new product development across both commercial and defense segments. The company targets sustained high-single-digit revenue growth through 2030 driven by aircraft delivery acceleration and services expansion. Near-term catalysts (0-12 months):- 737 MAX monthly production increase to 38 units by Q3 2026
- 777X certification completion and first customer deliveries
- Defense contract awards including potential $2.5B KC-135 modernization [S10]
- 787 Dreamliner production rate increases supporting wide-body market recovery
- Global Services segment expansion through digital solutions and predictive maintenance
- Space and defense diversification including lunar mission contracts [S7]
- Next-generation narrow-body aircraft development for 2030s market entry
- Sustainable aviation fuel and hybrid-electric propulsion technologies
- Autonomous systems and urban air mobility market participation
6b. Total Addressable Market (TAM)
Boeing operates in a $300B+ annual aerospace TAM growing at 4-5% annually driven by emerging market aviation demand and defense modernization. Commercial aviation represents $180B of annual opportunity while defense and space markets contribute $120B+ globally. Market positioning metrics:- Commercial narrow-body: 45% market share competing with Airbus
- Wide-body aircraft: 35% market share with 777 and 787 families
- Defense systems: 8% of global defense spending through diverse programs
- Services aftermarket: 25% share of $85B annual commercial services market
6c. Competitive Positioning
Boeing maintains co-leadership with Airbus in commercial aviation while competing against diversified defense contractors. The company's position faces challenges from Chinese manufacturers entering commercial markets and technology disruptors in defense applications.Competitive Reality: Boeing's duopoly position with Airbus provides structural advantages, though execution excellence remains critical for market share defense and margin expansion.
07 Management & Governance
7a. Leadership
CEO Dave Calhoun leads Boeing's operational recovery with 3+ years of crisis management experience since joining from General Electric in January 2020. The management team combines aerospace industry veterans with operational improvement specialists focused on safety and quality restoration. Key leadership assessment:- CEO Calhoun: Strong operational background with GE and Nielsen experience
- CFO Brian West: Joined from Refinitiv with extensive financial restructuring experience
- COO Stephanie Pope: Internal promotion with deep commercial aviation expertise
- Board composition: Industry-heavy with safety and engineering expertise additions since 2019
7b. Capital Allocation Track Record
Boeing's capital allocation during the recovery period prioritized balance sheet repair and production system restoration over shareholder returns. Management suspended dividends and share repurchases while investing $3.0B annually in manufacturing capabilities and R&D programs. Capital deployment priorities:- R&D investment: $2.8B annually supporting 777X and next-generation programs
- Manufacturing CapEx: $3.0B in 2025 for 737 MAX production expansion
- Debt reduction: Target 50% debt-to-capital ratio by 2028
- Shareholder returns: Suspended until FCF exceeds $4B annually
7c. Insider Ownership & Alignment
Insider ownership remains minimal at approximately 0.2% of outstanding shares, typical for large industrial companies but creating potential agency cost concerns. Executive compensation ties heavily to safety metrics and operational performance rather than stock price appreciation.Alignment Question: Low insider ownership limits direct financial alignment, though management incentives appropriately emphasize operational metrics over short-term stock performance during recovery.
08 Risk Analysis
8a. Company-Specific (Idiosyncratic) Risks
Boeing faces elevated execution risks across multiple programs while managing regulatory oversight and financial leverage. The company's operational complexity creates multiple single points of failure that could derail recovery trajectory.| Risk | Type | Probability | Impact | Mitigation |
|---|---|---|---|---|
| 737 MAX Production Delays | Operational | Medium | High | Supply chain diversification, quality controls |
| Regulatory Action | Compliance | Medium | High | Enhanced safety protocols, FAA cooperation |
| 777X Certification Issues | Technical | Medium | Medium | Conservative testing timeline, engineering resources |
| Defense Contract Losses | Competitive | Medium | Medium | Portfolio diversification, cost competitiveness |
| Debt Refinancing Risk | Financial | Low | High | Strong liquidity, debt maturity laddering |
8b. Industry & Macro (Systemic) Risks
Aerospace industry faces cyclical demand volatility and geopolitical tensions affecting both commercial and defense segments. Supply chain disruptions and labor constraints present ongoing operational challenges across the sector.| Risk | Type | Probability | Impact | Mitigation |
|---|---|---|---|---|
| Aviation Demand Decline | Cyclical | Medium | High | Diversified customer base, services revenue stability |
| Supply Chain Disruption | Operational | High | Medium | Supplier diversification, inventory buffers |
| Defense Budget Cuts | Political | Medium | Medium | International sales, commercial diversification |
Risk Concentration: Boeing's recovery depends heavily on 737 MAX execution success, creating concentrated risk that requires careful monitoring of production metrics and regulatory relationships.
09 Final Recommendation
12-Month Price Target
$285
+35.8% Implied Upside
Bull Case
$325
+54.8%
737 MAX production reaches 42/month by Q4 2026, defense margins expand to 12%, and 777X certification drives $8B revenue boost with 16x NTM P/E multiple expansion.
Base Case
$285
+35.8%
8% revenue CAGR through 2030 with normalized 8.5% operating margins generates $12B FCF by 2028, supporting 12x forward P/E valuation.
Bear Case
$235
+12.0%
Production delays limit 737 MAX to 32/month, regulatory issues delay 777X by 18 months, and defense margin compression sustains 8x P/E discount.
Valuation Methodology
Blended 65% DCF base case (10.2% WACC, 2.5% terminal growth, $285 intrinsic value) and 35% peer forward P/E of 12x applied to 2027E EPS of $23.75, weighted for operational risk recovery timeline and aerospace industry normalization.
5 Key Metrics to Watch
- 737 MAX Monthly Deliveries — Production rate directly drives revenue growth with each incremental aircraft worth $50M+ in revenue; target 38/month by Q3 2026
- Free Cash Flow Generation — FCF inflection to positive $2B+ quarterly run-rate signals sustainable recovery and debt reduction capability
- Defense Operating Margins — Margin expansion above 10% demonstrates program execution and competitive positioning in government contracts
- 777X Certification Timeline — FAA approval and first customer delivery unlocks $25B backlog and validates wide-body market recovery
- Net Debt Reduction — Progress toward $35B net debt target by 2028 enables investment grade rating restoration and dividend resumption
What Would Change Our Rating
| Action | Direction | Specific Trigger |
|---|---|---|
| Upgrade to Strong Buy | ↑ | 737 MAX production exceeds 40/month sustained for 2+ quarters |
| Downgrade to Hold | ↓ | Quarterly FCF remains negative beyond Q2 2026 |
| Downgrade to Sell | ↓↓ | Major regulatory action or 737 MAX production halt |
10 Open Questions & Narrative Checkpoints
What We Still Need To Underwrite: Boeing's recovery trajectory depends on flawless operational execution across multiple programs, with limited room for setbacks given current valuation expectations.
- Question: Can Boeing achieve 42 aircraft/month 737 MAX production by 2027 without compromising quality or safety protocols? Why it matters: Production rate directly drives $12B+ revenue upside and validates operational recovery narrative supporting premium valuation multiples.
- Question: Will FAA grant 777X certification by Q2 2026 or face additional delays similar to 737 MAX experience? Why it matters: 777X approval unlocks $25B backlog and demonstrates regulatory relationship restoration critical for future program approvals.
- Question: How sustainable are defense margin improvements given competitive pressures and potential budget constraints? Why it matters: Defense segment provides stable cash flow supporting overall profitability during commercial recovery phase.
- Question: Can Boeing generate positive free cash flow exceeding $4B annually by 2027 as working capital normalizes? Why it matters: FCF generation enables debt reduction, dividend restoration, and investment grade rating recovery essential for long-term competitiveness.
- Question: Will supply chain constraints limit 737 MAX production below target rates despite Boeing's delivery commitments? Why it matters: Supply chain bottlenecks could delay revenue recognition and margin improvement timeline by 6-12 months.
- Question: How will ongoing Starliner program criticism affect NASA contract renewals and broader space segment growth (as of March 2026)? Why it matters: Space programs provide long-term growth optionality and technological differentiation despite current execution challenges.
- Question: Can Boeing maintain market share against Airbus competition while focusing on production recovery over new product development? Why it matters: Market share erosion in key segments could permanently impair long-term profitability and competitive positioning.
- Question: Will elevated regulatory scrutiny result in additional compliance costs or operational constraints beyond current projections? Why it matters: Ongoing regulatory oversight could limit operational flexibility and increase compliance expenses affecting margin recovery timeline.
This report is for informational purposes only and does not constitute financial advice. Investors should conduct their own analysis and consult with financial professionals before making investment decisions.
11 Sources & Data As Of
Data Provenance: Live market data and company fundamentals are sourced from Yahoo Finance APIs and timestamped below. Narrative claims are grounded to evidence IDs referenced inline as
[S#].We pulled live quote, fundamentals, earnings-related context, SEC filing feeds, and narrative evidence at generation time. High-impact claims should be tied to Tier 1 sources where available.
Source modules used: quote, quoteSummary, fundamentalsTimeSeries, chart, server_clock, news, sec_filing.
Report Data Retrieval Timestamp: Mar 15, 2026, 8:19 PM
| ID | Type | Provider | Title | Trust | Published (UTC) |
|---|---|---|---|---|---|
[S2] |
fundamentals | Yahoo Finance | Yahoo quoteSummary fundamentals | Tier 1 | Mar 15, 2026, 8:19 PM |
[S3] |
fundamentals | Yahoo Finance | Yahoo annual financial statement history | Tier 1 | Mar 15, 2026, 8:19 PM |
[S4] |
market_history | Yahoo Finance | Yahoo 1Y chart snapshot | Tier 1 | Mar 15, 2026, 8:19 PM |
[S5] |
generation | Basis Report | Report generation timestamp | Tier 1 | Mar 15, 2026, 8:19 PM |
[S1] |
market_data | Yahoo Finance | Yahoo quote snapshot | Tier 1 | Mar 13, 2026, 8:00 PM |
[S15] |
sec_filing | Yahoo Finance (SEC filings) | Periodic Financial Reports | Tier 1 | Jan 30, 2026, 12:00 AM |
[S16] |
sec_filing | SEC EDGAR | 10-K - 10-K | Tier 1 | Jan 30, 2026, 12:00 AM |